Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX0TIR
|
||||
| Drug Name |
3-{19-methyl-14-oxo-3-propyl-3,13,19,20-tetraazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,21}]tricosa-1(16),2(10),4,6,8,11(15),17,20-octaen-7-yl}-1-[4-(methylsulfanyl)phenyl]urea
|
||||
| Synonyms |
CHEMBL219332
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C31H30N6O2S
|
||||
| Canonical SMILES |
CCCn1c2ccc(NC(=O)Nc3ccc(SC)cc3)cc2c4c5CNC(=O)c5c6c(CCc7nn(C)cc67)c14
|
||||
| InChI |
InChI=1S/C31H30N6O2S/c1-4-13-37-25-12-7-18(34-31(39)33-17-5-8-19(40-3)9-6-17)14-21(25)27-22-15-32-30(38)28(22)26-20(29(27)37)10-11-24-23(26)16-36(2)35-24/h5-9,12,14,16H,4,10-11,13,15H2,1-3H3,(H,32,38)(H2,33,34,39)
|
||||
| InChIKey |
HVRPPODXOQOJHV-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Angiopoietin 1 receptor | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathwayP00005:Angiogenesis | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.